Anna Postolova, MD

Offices

1 location · University Healthcare Alliance · 334 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Postolova’s office at (650) 498-6500 to ask if they take your plan before you enroll.

California Medical Board record

Licence A126882 · Current

Licensed to practise in California · since 2013 · expires 2027-04-30 · Tulane University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$156,332

Medicare paid this office $156,332 for 158 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Injection, omalizumab, 5 mg	11	$53,636	None
Long return visit (40+ min)	70	$20,965	$160
Return visit (30+ min)	102	$19,563	$114
New patient visit (60+ min)	21	$3,658	$174
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	107	$2,926	$14

See all 9 services

Sort by

Every Original Medicare service billed

Injection, omalizumab, 5 mg	11	$53,636	None
Long return visit (40+ min)	70	$20,965	$160
Return visit (30+ min)	102	$19,563	$114
New patient visit (60+ min)	21	$3,658	$174
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	107	$2,926	$14
New patient visit (45+ min)	17	$2,505	$147
Injection of drug or substance under skin or into muscle	18	$1,048	$14
Test to measure the level of nitric oxide gas	23	$542	$20
Test to measure expiratory airflow and volume	11	$263	$24

Who their Medicare patients are

158 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 9% · Women 77% · Health risk score 1.34. Above the middle of the specialty; the typical allergy/ immunology clinician is at 1.

Conditions among them: High blood pressure 59% · Coronary heart disease 25% · COPD 21% · Depression 20% · Cancer 18% · Atrial fibrillation 16% · Diabetes 15% · Chronic kidney disease 13% · Heart failure 11%.

The office billed $706,887, Medicare allowed $200,688 and paid $156,332; for 5,146 services of 25 kinds; $94,706 of it was for drugs given in the office and $61,626 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	158	5,146	73	1.34	$706,887	$156,332
2023	165	3,014	72	1.23	$423,200	$100,203
2022	155	5,578	72	1.24	$725,818	$168,669
2021	176	5,407	72	1.26	$662,417	$163,545
2020	126	2,325	71	1.44	$340,758	$78,018
2019	46	504	71	1.19	$85,982	$20,478

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	63	$21,948	$163
Return visit (30+ min)	84	$14,584	$106
New patient visit (60+ min)	29	$5,748	$198
New patient visit (45+ min)	32	$4,520	$141
Test for allergy using allergenic extract	19	$3,468	$4
Injection of drug or substance under skin or into muscle	11	$399	$14

2022: 7 services

Sort by

Original Medicare services billed in 2022

Injection, omalizumab, 5 mg	14	$58,108	None
Return visit (30+ min)	95	$17,847	$109
Long return visit (40+ min)	37	$9,397	$159
New patient visit (60+ min)	16	$3,045	$190
New patient visit (45+ min)	16	$1,756	$110
Short return visit (20+ min)	23	$1,457	$63
Injection of drug or substance under skin or into muscle	24	$1,408	$14

2021: 8 services

Sort by

Original Medicare services billed in 2021

Injection, omalizumab, 5 mg	15	$38,389	None
Return visit (30+ min)	99	$20,218	$118
Long return visit (40+ min)	51	$14,074	$164
New patient visit (60+ min)	47	$9,800	$209
New patient visit (45+ min)	34	$5,251	$154
Test for allergy using allergenic extract	14	$2,789	$4
Short return visit (20+ min)	15	$1,344	$90
Injection of drug or substance under skin or into muscle	20	$1,005	$14

2020: 6 services

Sort by

Original Medicare services billed in 2020

Long return visit (40+ min)	41	$12,263	$138
Return visit (30+ min)	59	$11,666	$102
New patient visit (60+ min)	42	$7,967	$190
New patient visit (45+ min)	22	$2,986	$136
Short return visit (20+ min)	21	$1,930	$69
Injection of drug or substance under skin or into muscle	15	$688	$14

2019: 3 services

Sort by

Original Medicare services billed in 2019

New patient visit (60+ min)	24	$4,526	$189
Return visit (30+ min)	22	$2,839	$101
Long return visit (40+ min)	12	$2,156	$135

Drugs they prescribed that Part D paid

$561,175

Pharmacies billed $561,175 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

343 generic and 173 brand-name prescriptions · $561,175 in drug cost · 16 antibiotic prescriptions to 12 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Actemra Actpen	33	$136,866	$4,147
Orencia Clickject	20	$117,301	$5,865
Humira(Cf)	17	$111,823	$6,578
Otezla	12	$56,583	$4,715
Prednisone	82	$1,170	$14

See all 14 drugs

Sort by

Every Part D drug this clinician prescribed

Actemra Actpen	33	$136,866	$4,147
Orencia Clickject	20	$117,301	$5,865
Humira(Cf)	17	$111,823	$6,578
Otezla	12	$56,583	$4,715
Prednisone	82	$1,170	$14
Hydroxychloroquine Sulfate	15	$875	$58
Colchicine	17	$811	$48
Methotrexate	24	$705	$29
Febuxostat	13	$530	$41
Ipratropium	11	$343	$31
Azelastine	11	$284	$26
Alendronate	13	$277	$21
Montelukast	26	$267	$10
Allopurinol	17	$163	$10

Year by year

Sort by

Part D prescribing by year

2024	516	129	None	34%	$561,175
2023	388	108	None	None	$531,895
2022	448	130	None	None	$458,538
2021	492	132	None	None	$364,244
2020	446	94	None	None	$211,341
2019	103	35	0% (0)	23%	$83,184

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Sort by

Part D drugs prescribed in 2023

Orencia Clickject	18	$106,306	$5,906
Febuxostat	16	$1,482	$93
Colchicine	15	$1,045	$70
Leflunomide	13	$990	$76
Azelastine	23	$754	$33
Prednisone	62	$649	$10
Hydroxychloroquine Sulfate	12	$501	$42
Sulfasalazine	13	$474	$36
Methotrexate	14	$383	$27
Alendronate	12	$239	$20
Allopurinol	12	$190	$16
Montelukast	12	$112	$9

2022: 14 drugs

Sort by

Part D drugs prescribed in 2022

Enbrel Sureclick	15	$110,632	$7,375
Enbrel	13	$90,064	$6,928
Humira(Cf)	12	$87,256	$7,271
Actemra Actpen	12	$50,513	$4,209
Symbicort	18	$10,933	$607
Trelegy Ellipta	12	$7,950	$663
Hydroxychloroquine Sulfate	23	$1,704	$74
Leflunomide	11	$1,544	$140
Azelastine	29	$1,335	$46
Methotrexate	24	$1,162	$48
Prednisone	66	$741	$11
Albuterol Sulfate Hfa	14	$578	$41
Fluticasone Propionate	12	$245	$20
Montelukast	12	$81	$7

2021: 11 drugs

Sort by

Part D drugs prescribed in 2021

Humira(Cf)	13	$116,698	$8,977
Trelegy Ellipta	23	$13,382	$582
Methotrexate	27	$2,627	$97
Leflunomide	22	$2,524	$115
Hydroxychloroquine Sulfate	27	$1,993	$74
Prednisone	124	$1,444	$12
Ipratropium	17	$705	$41
Levocetirizine Dihydrochloride	11	$509	$46
Diclofenac	15	$308	$21
Alendronate	17	$180	$11
Montelukast	13	$125	$10

2020: 9 drugs

Sort by

Part D drugs prescribed in 2020

Humira(Cf)	13	$77,076	$5,929
Breo Ellipta	12	$4,499	$375
Prednisone	150	$1,471	$10
Hydroxychloroquine Sulfate	25	$1,248	$50
Diclofenac	21	$419	$20
Methotrexate	11	$275	$25
Montelukast	19	$240	$13
Alendronate	17	$150	$9
Allopurinol	12	$141	$12

2019: 2 drugs

Sort by

Part D drugs prescribed in 2019

Azathioprine	11	$372	$34
Prednisone	31	$282	$9

Money from drug and device companies

$2,560 in 2025

Sort by

Industry payments by year

2025	3	7	$2,400	$2,560
2024	4	6	None	$159
2023	3	6	None	$130
2022	1	1	None	$50
2021	1	1	None	$13
2020	3	3	None	$117
2019	5	14	None	$423

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Progentec Diagnostics	None	$2,400	1 payment Consulting · 2025-07-23 · $2,400
Novartis Pharmaceuticals	Cosentyx	$143	5 payments Meals for Rhapsido · 2025-12-05 · $26 Meals · 2025-07-22 · $71 Meals for Cosentyx · 2025-06-26 · $15 Meals for Cosentyx · 2025-03-20 · $15 Meals for Cosentyx · 2025-01-10 · $16
CSL Behring	Andembry	$17	1 payment Meals for Andembry · 2025-09-17 · $17

See all 7 published payments

Sort by

Every published payment

Novartis Pharmaceuticals	Meals · 2025-12-05	Rhapsido	$26
CSL Behring	Meals · 2025-09-17	Andembry	$17
Progentec Diagnostics	Consulting · 2025-07-23	None	$2,400
Novartis Pharmaceuticals	Meals · 2025-07-22	None	$71
Novartis Pharmaceuticals	Meals · 2025-06-26	Cosentyx	$15
Novartis Pharmaceuticals	Meals · 2025-03-20	Cosentyx	$15
Novartis Pharmaceuticals	Meals · 2025-01-10	Cosentyx	$16

See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $159

Sort by

Payments by company in 2024

Novartis Pharmaceuticals	Cosentyx	$56	3 payments Meals for Cosentyx · 2024-11-14 · $14 Meals for Cosentyx · 2024-07-02 · $15 Meals for Cosentyx · 2024-04-30 · $26
AstraZeneca Pharmaceuticals LP	Airsupra	$53	1 payment Meals for Airsupra · 2024-10-26 · $53
GlaxoSmithKline	Benlysta	$29	1 payment Meals for Benlysta · 2024-02-02 · $29
Genentech USA	Xolair	$21	1 payment Meals for Xolair · 2024-03-12 · $21

2023: $130

Sort by

Payments by company in 2023

Novartis Pharmaceuticals	Cosentyx	$92	4 payments Meals for Cosentyx · 2023-10-17 · $20 Meals for Cosentyx · 2023-03-02 · $25 Meals for Cosentyx · 2023-02-07 · $26 Meals for Cosentyx · 2023-01-19 · $20
GlaxoSmithKline	Benlysta	$23	1 payment Meals for Benlysta · 2023-05-12 · $23
Pfizer	Cibinqo	$15	1 payment Education for Cibinqo · 2023-04-06 · $15

2022: $50

Sort by

Payments by company in 2022

Gilead Sciences	None	$50	1 payment Meals · 2022-02-18 · $50

2021: $13

Sort by

Payments by company in 2021

GlaxoSmithKline	Nucala	$13	1 payment Meals for Nucala · 2021-05-19 · $13

2020: $117

Sort by

Payments by company in 2020

Amgen	Enbrel	$81	1 payment Meals for Enbrel · 2020-01-07 · $81
Pharming Healthcare	Ruconest	$20	1 payment Meals for Ruconest · 2020-10-01 · $20
GlaxoSmithKline	Nucala	$16	1 payment Meals for Nucala · 2020-06-17 · $16

2019: $423

Sort by

Payments by company in 2019

GlaxoSmithKline	Benlysta	$194	5 payments Meals for Benlysta · 2019-11-20 · $30 Meals for Benlysta · 2019-11-19 · $3 Meals for Nucala · 2019-09-13 · $24 Meals for Benlysta · 2019-08-20 · $15 Meals for Benlysta · 2019-04-04 · $122
Amgen	Evenity	$161	5 payments Meals for Evenity · 2019-11-13 · $29 Meals for Evenity · 2019-09-25 · $18 Meals for Enbrel · 2019-09-17 · $25 Meals for Enbrel · 2019-09-11 · $21 Meals for Evenity · 2019-08-21 · $67
AstraZeneca Pharmaceuticals LP	Symbicort	$29	2 payments Meals for Symbicort · 2019-10-15 · $11 Meals for Symbicort · 2019-08-10 · $18
Kaleo	Auvi-Q	$22	1 payment Meals for Auvi-Q · 2019-09-10 · $22
E.R. Squibb & Sons L.L.C.	Orencia	$17	1 payment Meals for Orencia · 2019-10-15 · $17

Professional record

NPI: 1932475316
Licence: CA A126882California A126882: Current · expires 2027-04-30
Trained: Tulane University School of Medicine, 2012
Group: University Healthcare Alliance
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207K00000X (207K00000X); Internal medicine (207R00000X); Federal specialty code 207RA0201X (207RA0201X); Federal specialty code 207RR0500X (207RR0500X)
Mailing address: 1300 Crane St, Menlo Park, CA, 94025
NPI first listed: 2012-03-29
NPI last updated: 2024-04-16
NPI record certified: 2024-04-16

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Drive, Stanford, CA, 94305